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Introduction
No previous studies have assessed quality of life (QoL)
in idiopathic intracranial hypertension (IIH) associated
with a therapeutic weight loss. Our previously published
prospective cohort study confirmed that weight loss sig-
nificantly reduced intracranial pressure (ICP) and trea-
ted chronic active adult IIH.
AIMS
Evaluate if QoL improved following treatment of IIH
achieved through weight loss. Additionally, evaluate the
relationship between QoL and changes in clinical out-
come measures (body mass index (BMI), ICP (lumbar
puncture), papilloedema (optical coherence tomography
retinal nerve fibre layer thickness), automated perimetry
(Humphrey visual field 24-2), LogMar visual acuity as
well as headache severity (diarised verbal rating scale
0-10) and disability (headache impact test-6).
Method
QoL was assessed using the short form 36 questionnaire
(SF-36) before and after a dietary intervention and com-
pared to changes in clinical outcomes. Baseline QoL was
also compared to a control cohort.
Results
At baseline, SF-36 scores were worse in IIH group com-
pared to an age-matched population. Following therapeu-
tic weight loss, with reduction of ICP (p < 0.001), SF-36
significantly improved (8 out of 11 domains). Despite a
significant improvement with therapeutic weight loss, the
following were not associated with enhanced quality of
life: ICP, papilloedema, automated perimetry, visual
acuity and BMI. The only variables that significantly cor-
related with improved QoL were headache severity and
disability, p < 0.001.
Conclusion
QoL significantly improved in IIH following therapeutic
weight loss with reduction in ICP. Improvement in
headache was the only factor that correlated with
enhanced QoL. Effective headache management is a
vital determinant of QoL in IIH.
No conflict of interest.
Authors’ details
1Neurotrauma and Neurodegeneration School of Clinical and Experimental
Medicine College of Medical and Dental Sciences, University of Birmingham,
Birmingham, UK. 2Birmingham Clinical Trials Unit, University of Birmingham,
Birmingham, UK.
Published: 18 September 2014
doi:10.1186/1129-2377-15-S1-C57
Cite this article as: Sinclair et al.: EHMTI-0304. Headache determines
quality of life in idiopathic intracranial hypertension. The Journal of
Headache and Pain 2014 15(Suppl 1):C57.
Submit your manuscript to a 
journal and benefi t from:
7 Convenient online submission
7 Rigorous peer review
7 Immediate publication on acceptance
7 Open access: articles freely available online
7 High visibility within the fi eld
7 Retaining the copyright to your article
    Submit your next manuscript at 7 springeropen.com
1Neurotrauma and Neurodegeneration School of Clinical and Experimental
Medicine College of Medical and Dental Sciences, University of Birmingham,
Birmingham, UK
Full list of author information is available at the end of the article
Sinclair et al. The Journal of Headache and Pain 2014, 15(Suppl 1):C57
http://www.thejournalofheadacheandpain.com/content/15/S1/C57
© 2014 Sinclair et al; licensee Springer. This is an Open Access article distributed under the terms of the Creative Commons Attribution
License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium,
provided the original work is properly cited.
